Internet Archive Scholar

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

Amélie Darlix, Christophe Hirtz, Simon Thezenas, Aleksandra Maceski, Audrey Gabelle, Evelyne Lopez-Crapez, Hélène De Forges, Nelly Firmin, Séverine Guiu, William Jacot, Sylvain Lehmann
2019 BMC Cancer  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (1.3 MB)
https://web.archive.org/web/20190430160801/https://www.hal.inserm.fr/inserm-02050007/document

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL. The file type is application/pdf.

doi:10.1186/s12885-019-5287-z fatcat:kcipn5k2m5gabfdxqnw73fqlna
DOAJ
Citation

Amélie Darlix, Christophe Hirtz, Simon Thezenas, Aleksandra Maceski, Audrey Gabelle, Evelyne Lopez-Crapez, Hélène De Forges, Nelly Firmin, Séverine Guiu, William Jacot, Sylvain Lehmann. "The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases." BMC Cancer 19.1 (2019)